Publicaciones (166) Publicaciones de MARÍA ISABEL FABREGAT ROMERO

2023

  1. Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models

    Journal of Experimental and Clinical Cancer Research, Vol. 42, Núm. 1

  2. Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models (Journal of Experimental & Clinical Cancer Research, (2023), 42, 1, (197), 10.1186/s13046-023-02780-4)

    Journal of Experimental and Clinical Cancer Research

  3. Dissecting the role of the NADPH oxidase NOX4 in TGF-beta signaling in hepatocellular carcinoma

    Redox Biology, Vol. 65

  4. The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC progression

    Hepatology, Vol. 78, Núm. 2, pp. 416-433

2022

  1. Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC-induced cholestatic injury by promoting a pro-restorative inflammatory response

    Journal of Pathology, Vol. 258, Núm. 3, pp. 312-324

  2. Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals

    Hepatology, Vol. 75, Núm. 3, pp. 550-566

  3. Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular Carcinoma

    Cancers, Vol. 14, Núm. 8

  4. The Tumor Microenvironment Drives Intrahepatic Cholangiocarcinoma Progression

    International Journal of Molecular Sciences, Vol. 23, Núm. 8

2021

  1. 2-[18f]fdg pet/ct as a predictor of microvascular invasion and a high histological grade in patients with a hepatocellular carcinoma

    Cancers, Vol. 13, Núm. 11

  2. Anti-TGFβ (Transforming Growth Factor β) Therapy With Betaglycan-Derived P144 Peptide Gene Delivery Prevents the Formation of Aortic Aneurysm in a Mouse Model of Marfan Syndrome

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 41, Núm. 9, pp. E440-E452

  3. Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity

    Cell Death and Disease, Vol. 12, Núm. 6

  4. Direct and indirect effect of tgfβ on treg transendothelial recruitment in hcc tissue microenvironment

    International Journal of Molecular Sciences, Vol. 22, Núm. 21

  5. Epithelial–mesenchymal transition (Emt) induced by tgf-β in hepatocellular carcinoma cells reprograms lipid metabolism

    International Journal of Molecular Sciences, Vol. 22, Núm. 11

  6. NADPH oxidase 4 (Nox4) deletion accelerates liver regeneration in mice

    Redox Biology, Vol. 40

  7. The tgf-β /nadph oxidases axis in the regulation of liver cell biology in health and disease

    Cells, Vol. 10, Núm. 9

  8. The tgf-β pathway: A pharmacological target in hepatocellular carcinoma?

    Cancers, Vol. 13, Núm. 13

2020

  1. A Signaling Crosstalk between BMP9 and HGF/c-Met Regulates Mouse Adult Liver Progenitor Cell Survival

    Cells, Vol. 9, Núm. 3

  2. Case Report: An EGFR-Targeted 4-1BB-agonistic Trimerbody Does Not Induce Hepatotoxicity in Transgenic Mice With Liver Expression of Human EGFR

    Frontiers in Immunology, Vol. 11

  3. Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancer

    Journal of Hepatology, Vol. 72, Núm. 1, pp. 125-134

  4. Editorial Special Issue TGF-beta/BMP Signaling Pathway

    Cells